✦ LIBER ✦
399 POSTER A Phase 1 dose-escalation, pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of intravenous LY2275796 (LY), an eIF-4E antisense oligonucleotide (ASO) in patients with advanced solid tumors
✍ Scribed by G.R. Simon; M. Fishman; A.M. Dellaportas; D. Sullivan; L.H. Brail; V. Andre; S. Callies; U. Aytac; D. Hong; Y. Oh
- Book ID
- 119599555
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 61 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.